GENE ONLINE|News &
Opinion
Blog

Samsung Bioepis
GeneOnline’s Weekly News Highlights: Sept 11-Sept 15
2023-09-19
Samsung Biologics Snaps Up Biogen’s Stake in Samsung Bioepis for $2.3 Billion, Assuming Full Control of Biosimilar Venture
2022-01-28
FDA Approves Samsung Bioepis and Biogen’s Lucentis Biosimilar
2021-09-22
Samsung Bioepis Presents 5-Year Follow-up Results on Trastuzumab Biosimilar at ESMO 2021
2021-09-13
South Korea’s Boryung Launches Avastin Biosimilar Developed by Samsung Bioepis
2021-09-02
Korea Made Humira Biosimilar Begins Sales in Australia, Marks its Presence in Third Overseas Market
2021-03-31
Two South Korean Companies Look to Capture the Biosimilars Market Worth Billions
2020-12-01
Weekly Cover: Acepodia’s NK Cell Therapy Drug Candidate ACE1702 Receives FDA Clearance of IND
2020-01-15
Samsung Bioepis Expects to Earn Profits for the First Time in Eight Years
2019-11-12
Weekly in Asia |Nov
2019-11-12
Weekly in Asia 2019|JUL
2019-08-02
LATEST
Gene Therapy Achieves Complete Cure for Sickle Cell Anemia in New York Patient
2025-03-17
NICE Recommends New Endometriosis Treatment for NHS Patients
2025-03-14
Mallinckrodt and Endo Announce $6.7 Billion Merger Agreement
2025-03-14
Study Finds Married Men Three Times More Likely to Be Obese Than Single Men
2025-03-14
Lower Waist-to-Hip Ratio in Midlife Associated with Better Cognitive Function in Later Years
2025-03-14
Study Identifies Role of C-reactive Protein in Diabetic Kidney Inflammation
2025-03-14
Study Finds Semisynthetic Bile Acid Reduces Pro-Inflammatory Cells in Gut
2025-03-14
EVENT
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
Scroll to Top